Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
261 | 41136 | 44.7 | 86% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
412 | 16030 | GENE DELIVERY//GENE THERAPY//POLYETHYLENIMINE |
1188 | 8871 | ANTIMICROBIAL PEPTIDE//ANTIMICROBIAL PEPTIDES//DEFENSINS |
1483 | 7123 | PIRNA//RNA INTERFERENCE//PIWI |
1512 | 6953 | ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE |
2971 | 2159 | CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GENE DELIVERY | Author keyword | 880 | 47% | 3% | 1382 |
2 | GENE THERAPY | Author keyword | 831 | 23% | 8% | 3212 |
3 | ANTIMICROBIAL PEPTIDE | Author keyword | 820 | 54% | 3% | 1057 |
4 | ANTIMICROBIAL PEPTIDES | Author keyword | 535 | 47% | 2% | 843 |
5 | HUMAN GENE THERAPY | Journal | 444 | 34% | 3% | 1079 |
6 | ADENOVIRUS | Author keyword | 434 | 27% | 3% | 1349 |
7 | MOLECULAR THERAPY | Journal | 403 | 32% | 3% | 1050 |
8 | ONCOLYTIC VIRUS | Author keyword | 374 | 76% | 1% | 259 |
9 | CELL PENETRATING PEPTIDE | Author keyword | 361 | 65% | 1% | 347 |
10 | DEFENSINS | Author keyword | 312 | 48% | 1% | 482 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GENE DELIVERY | 880 | 47% | 3% | 1382 | Search GENE+DELIVERY | Search GENE+DELIVERY |
2 | GENE THERAPY | 831 | 23% | 8% | 3212 | Search GENE+THERAPY | Search GENE+THERAPY |
3 | ANTIMICROBIAL PEPTIDE | 820 | 54% | 3% | 1057 | Search ANTIMICROBIAL+PEPTIDE | Search ANTIMICROBIAL+PEPTIDE |
4 | ANTIMICROBIAL PEPTIDES | 535 | 47% | 2% | 843 | Search ANTIMICROBIAL+PEPTIDES | Search ANTIMICROBIAL+PEPTIDES |
5 | ADENOVIRUS | 434 | 27% | 3% | 1349 | Search ADENOVIRUS | Search ADENOVIRUS |
6 | ONCOLYTIC VIRUS | 374 | 76% | 1% | 259 | Search ONCOLYTIC+VIRUS | Search ONCOLYTIC+VIRUS |
7 | CELL PENETRATING PEPTIDE | 361 | 65% | 1% | 347 | Search CELL+PENETRATING+PEPTIDE | Search CELL+PENETRATING+PEPTIDE |
8 | DEFENSINS | 312 | 48% | 1% | 482 | Search DEFENSINS | Search DEFENSINS |
9 | SIRNA | 298 | 25% | 3% | 1039 | Search SIRNA | Search SIRNA |
10 | CELL PENETRATING PEPTIDES | 277 | 66% | 1% | 259 | Search CELL+PENETRATING+PEPTIDES | Search CELL+PENETRATING+PEPTIDES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYETHYLENIMINE | 816 | 58% | 2% | 937 |
2 | ANTIMICROBIAL PEPTIDES | 807 | 34% | 5% | 1912 |
3 | TRANSFECTION EFFICIENCY | 762 | 63% | 2% | 772 |
4 | SMALL INTERFERING RNAS | 702 | 45% | 3% | 1164 |
5 | HOST DEFENSE PEPTIDES | 610 | 68% | 1% | 533 |
6 | ARGININE RICH PEPTIDES | 599 | 75% | 1% | 433 |
7 | PLASMID DNA | 572 | 26% | 5% | 1881 |
8 | DNA COMPLEXES | 550 | 65% | 1% | 528 |
9 | TRANSGENE EXPRESSION | 524 | 36% | 3% | 1173 |
10 | TRANSFECTION | 510 | 32% | 3% | 1297 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE THERAPY | 536 | 34% | 3% | 1286 |
2 | HUMAN GENE THERAPY | 444 | 34% | 3% | 1079 |
3 | MOLECULAR THERAPY | 403 | 32% | 3% | 1050 |
4 | CANCER GENE THERAPY | 253 | 34% | 1% | 615 |
5 | JOURNAL OF GENE MEDICINE | 239 | 37% | 1% | 510 |
6 | JOURNAL OF CONTROLLED RELEASE | 84 | 11% | 2% | 728 |
7 | BIOCONJUGATE CHEMISTRY | 59 | 11% | 1% | 504 |
8 | CURRENT GENE THERAPY | 48 | 28% | 0% | 145 |
9 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 30 | 18% | 0% | 155 |
10 | JOURNAL OF PEPTIDE SCIENCE | 25 | 12% | 0% | 199 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Knocking down barriers: advances in siRNA delivery | 2009 | 927 | 98 | 81% |
Non-viral vectors for gene-based therapy | 2014 | 89 | 148 | 65% |
Antimicrobial peptides of multicellular organisms | 2002 | 3508 | 69 | 62% |
Nonviral Vectors for Gene Delivery | 2009 | 865 | 526 | 64% |
Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? | 2005 | 1735 | 149 | 72% |
Delivery materials for siRNA therapeutics | 2013 | 159 | 105 | 66% |
Cell-Penetrating Peptides: Design, Synthesis, and Applications | 2014 | 50 | 216 | 79% |
PIWI-interacting small RNAs: the vanguard of genome defence | 2011 | 277 | 94 | 85% |
Oncolytic virotherapy | 2012 | 203 | 158 | 75% |
The promises and pitfalls of RNA-interference-based therapeutics | 2009 | 548 | 93 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE THER Y | 258 | 29% | 1.8% | 738 |
2 | HUMAN GENE THER Y | 243 | 51% | 0.8% | 342 |
3 | CANC GENE THER Y GRP | 117 | 72% | 0.2% | 91 |
4 | GENE TRANSFER REGULAT | 75 | 74% | 0.1% | 56 |
5 | GENE THER Y PROGRAM | 73 | 34% | 0.4% | 174 |
6 | SAN DIEGO SCI | 63 | 70% | 0.1% | 53 |
7 | POWELL GENE THER Y | 53 | 38% | 0.3% | 111 |
8 | SYST BASED DRUG | 49 | 79% | 0.1% | 31 |
9 | BIOPHARMACEUT DRUG METAB | 42 | 46% | 0.2% | 69 |
10 | MOL MED GENE THER Y UNIT | 42 | 72% | 0.1% | 33 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000004347 | GENOME EDITING//CAS9//CRISPR |
2 | 0.0000003884 | SOLID LIPID NANOPARTICLES//L ASPARAGINASE//NANOSTRUCTURED LIPID CARRIERS |
3 | 0.0000003124 | MICRORNA//MICRORNAS//MIRNA |
4 | 0.0000002989 | DENDRIMERS//DENDRIMER//OXIDATIVE POLYCONDENSATION |
5 | 0.0000002187 | MERKEL CELL CARCINOMA//P53//JC VIRUS |
6 | 0.0000001884 | LANGMUIR//JOURNAL OF COLLOID AND INTERFACE SCIENCE//LANGMUIR BLODGETT FILMS |
7 | 0.0000001767 | JOURNAL OF IMMUNOLOGY//IMMUNOL//DENDRITIC CELLS |
8 | 0.0000001699 | ELECTROCHEMOTHERAPY//ELECTROPERMEABILIZATION//ELECTROPORATION |
9 | 0.0000001598 | CLICK CHEMISTRY//SOLID PHASE SYNTHESIS//FOLDAMERS |
10 | 0.0000001519 | BIOLUMINESCENCE//LAMPYRIDAE//COELENTERAZINE |